FREDERICK, Md., June 10, 2013 /PRNewswire/ – BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, which has sold 500,000 devices, without prescriptions, in 57 countries reported that they have received three letters from the Office of Science Integrity.  These letters are virtually identical in denying the firm’s request for the FDA Commissioner…

Ex-Im Bank Provides Export Financing Support FREDERICK, Md., May 29, 2013 /PRNewswire/ – BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, is pleased to announce it has been issued a $500,000 Line of Credit from Ex-Im Bank to create jobs and assist with export working capital. The funding will enable BioElectronics to…

Public Advisory Panel Accepts FDA’s Class II Re-Classification Suggestion FREDERICK, Md., May 23, 2013 /PRNewswire/ – BioElectronics Corporation (OTC Pink: BIEL), the maker of very effective, safe consumer medical devices, comments on the FDA panel meeting for non-thermal shortwave diathermy: The FDA’s Public Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting was held on May 21,…

Confirmation of Physiological Mechanism for Pain Relief FREDERICK, MD — 5/21/2013 — BioElectronics Corp. (OTC Pink: BIEL), the maker of inexpensive, disposable drug-free consumer electronic devices, announced that CEO, Andrew J. Whelan is presenting today to the FDA’s Medical Advisory Committee, Orthopedic and Rehabilitation Panel compelling arguments for reclassifying the company’s products for over the…

FREDERICK, MD, May 7, 2013 /PRNewswire/ — BioElectronics Corporation (OTC PINK: BIEL), maker of consumer medical electronics, announced today that the World Intellectual Property Organization, International Bureau has published its new patent (#WO2013059804) “Pulsed Electromagnetic Field Device with Adhesive Applicator”. The new patent combines Pulsed Electromagnetic Field (PEMF) Technology with the combining of an adhesive…

FREDERICK, Md., May 2, 2013 /PRNewswire/ – BioElectronics Corporation (OTC Pink: BIEL), the maker of unique, safe, inexpensive, patented, pain products announced today that it has established distribution in Iraq with Mazaya Scientific Bureau for its ActiPatch® musculoskeletal therapy, Allay™ menstrual pain, and RecoveryRx™ post-operative and chronic wound products. Mazaya Scientific Bureau (www.mazaya-sb.com) is a leading…

FREDERICK, Md., April 11, 2013 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of unique, safe, inexpensive over-the-counter pulsed shortwave therapy, announced today that it has established distribution in Peru of its ActiPatch Therapy, treatment of back, knee, elbow and other pain and musculoskeletal issues, and its Allay menstrual cycle pain therapy. Sistemas Analiticos…

FREDERICK, Md., April 9, 2013 /PRNewswire/ – BioElectronics Corporation (OTC Pink: BIEL), the maker of unique inexpensive, patented, technological solutions for chronic and post-operative wound care, announced today that it has established a Venezuelan distributor for its ActiPatch® Pain Relief Therapy and RecoveryRx™ Postoperative and Wound Care Recovery medical devices that provide labor free, 24-hour therapy…

FREDERICK, Md., April 3, 2013 /PRNewswire/ – BioElectronics Corporation (OTC Pink: BIEL), the maker of unique pain relief, inexpensive, patented, consumer medical devices announced today that it has begun product distribution of its ActiPatch® Musculoskeletal Pain Relief,  Allay™ Menstrual Pain Therapy and RecoveryRx™ Chronic and Postoperative wound therapy brands with Herapharm Co. Ltd, www.herapharm.co.kr. Herapharm has…

FREDERICK, Md., April 1, 2013 /PRNewswire/ – BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics, announced today that the Company has received notice from the United States Patent and Trademark Office that patent number 8,412,328 is being issued. This new US patent, our 5 other US patents, and 2 pending provide us sound intellectual…